SCHEMBL14082228

SCHEMBL14082228

Cc1c(Br)cc(/C=N/NC(=O)CNc2ccc(Cl)cc2)cc1Br

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GRK2 P25098 7/20 0.63
▸ ROCK2 O75116 3/20 0.63
▸ MAPT P10636 6/20 0.58
▸ MEN1 O00255 3/20 0.58
▸ KMT2A Q03164 3/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ GAA P10253 2/20 0.54
▸ KDM4E B2RXH2 2/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.52
▸ HTT P42858 1/20 0.52
▸ LIG1 P18858 2/20 0.51
▸ LIG3 P49916 1/20 0.51
▸ GRK3 P35626 1/20 0.50
▸ LMNA P02545 1/20 0.49
▸ ERCC1 P07992 1/20 0.48
▸ ERCC4 Q92889 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL690273 0.89 GRK2 (0.65) GRK2ROCK2MAPTMEN1KMT2A
SCHEMBL690272 0.89 GRK2 (0.65) GRK2ROCK2MAPTMEN1KMT2A
SCHEMBL1670001 0.85 GRK2 (0.62) GRK2ROCK2MAPTMEN1KMT2A
SCHEMBL1669998 0.85 GRK2 (0.62) GRK2ROCK2MAPTMEN1KMT2A
SCHEMBL14082231 0.84 CFTR (0.59) GRK2ROCK2MAPTMEN1KMT2A
SCHEMBL14082217 0.83 MEN1 (0.67) GRK2MAPTMEN1KMT2AMAPK1
SCHEMBL1669993 0.82 GRK2 (0.65) GRK2ROCK2MAPTMEN1KMT2A
SCHEMBL1669995 0.82 GRK2 (0.65) GRK2ROCK2MAPTMEN1KMT2A
SCHEMBL14082240 0.82 MEN1 (0.63) GRK2MAPTMEN1KMT2AMAPK1
SCHEMBL3631238 0.82 GRK2 (0.55) GRK2ROCK2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414037-B2 cystic fibrosis transmembrane conductance regulator protein inhibitor; 2-naphthalenylamino-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene][3-[4-(3-(PEG)n-thioureido)diphenyl)-thioureido]propanedioic acid dihydrazide (MalH-(PEG)nB); cystic fibrosis with forms of male infertility, secretory diarrhea THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-08-19 — — US disclosed
Send feedback